Author Correction: Tripterygium wilfordii cytochrome P450s catalyze the methyl shift and epoxidations in the biosynthesis of triptonide

Author Correction: Tripterygium wilfordii cytochrome P450s catalyze the methyl shift and epoxidations in the biosynthesis of triptonide

Saved in:

Bibliographic Details
Main Authors:	Kenneth T. Kongstad, Nikolaj Lervad Hansen, Louise Kjaerulff, Quinn Kalby Heck, Victor Forman, Dan Staerk, Birger Lindberg Møller, Johan Andersen-Ranberg
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-07-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-025-62209-8
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tripterygium wilfordii cytochrome P450s catalyze the methyl shift and epoxidations in the biosynthesis of triptonide
by: Nikolaj Lervad Hansen, et al.
Published: (2022-08-01)

Research on nanoemulsion for increasing effects and reducing toxicity of Tripterygium wilfordii polyglycosides
by: HE Xin, et al.
Published: (2008-05-01)

Progress on Tripterygium wilfordii Hook f. as a treatment option for neurodegenerative diseases
by: Zhong-mou Zhang, et al.
Published: (2024-12-01)

Genome-wide characterization and expression analysis of WRKY family genes in the biosynthesis of triptolide in Tripterygium wilfordii
by: Limei Tang, et al.
Published: (2025-04-01)

Meta-analysis of efficacy and safety of multi-glycoside of Tripterygium wilfordii in the treatment of idiopathic membranous nephropathy
by: YIN Song-jiang, et al.
Published: (2016-01-01)

Therapeutic effects and mechanisms of Tripterygium wilfordii extracts in rheumatoid arthritis: a systematic review and meta-analysis of preclinical studies
by: Kai Chen, et al.
Published: (2025-07-01)

The emerging role of mitochondria in the pharmacological and toxicological effects of Tripterygium wilfordii Hook F: functions, targets and new therapeutic applications
by: Zhonghao Liu, et al.
Published: (2025-07-01)

Bacterial Cytochrome P450 Catalyzed Macrocyclization of Ribosomal Peptides
by: Jing Liu, et al.
Published: (2024-11-01)

A network Meta-analysis of tripterygium wilfordii polyglycosides tablet,ambrette capsule and RAS blocker in the treatment of IgA nephropathy
by: FANG Xin-ying, et al.
Published: (2020-01-01)

Combination of Tripterygium Wilfordii Hook F With Antiretroviral Therapy Delayed Viral Rebound in A Patient of Acute HIV-1 Infection
by: Wei Cao, et al.
Published: (2021-07-01)

Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides
by: Xu Fangdan, et al.
Published: (2025-01-01)

Cytochromes P450, Oxygen, and Evolution
by: David F.V. Lewis, et al.
Published: (2001-01-01)

Efficacy and Safety of Glycosides of Tripterygium wilfordii Combined with Renin-Angiotensin System in the Treatment of IgA Nephropathy: A Systematic Review and Meta-Analysis
by: Ming Chen, et al.
Published: (2022-01-01)

Structure Characterization of Four New Sesquiterpene Pyridine Alkaloids from <i>Tripterygium wilfordii</i> Hook. f. and Anti-Inflammatory Activity Evaluations
by: Yong-Jian Wang, et al.
Published: (2024-11-01)

The role of the cytochrome P450 superfamily in the skin
by: Qianqian Chen, et al.
Published: (2024-01-01)

Retracted: Efficacy and Safety of Tripterygium Wilfordii Glycoside Tablets Combined with Acitretin Capsules in the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

Retracted: Efficacy and Safety of Glycosides of Tripterygium wilfordii Combined with Renin-Angiotensin System in the Treatment of IgA Nephropathy: A Systematic Review and Meta-Analysis
by: Emergency Medicine International
Published: (2023-01-01)

The effects of Tripterygium wilfordii Hook F on renal outcomes in type 2 diabetic kidney disease patients with severe proteinuria: a single-center cohort study
by: Yaqi Cheng, et al.
Published: (2024-12-01)

Structural Models for Cytochrome P450�Mediated Catalysis
by: David F.V. Lewis
Published: (2003-01-01)

Properties of “Stable” Mosquito Cytochrome P450 Enzymes
by: George Tzotzos
Published: (2025-02-01)

Cytochrome P450-catalyzed allylic oxidation of pentalenene to 1-deoxypentalenic acid in pentalenolactone biosynthesis
by: Jing Li, et al.
Published: (2025-06-01)

Dietary Omega-3 Polyunsaturated Fatty Acids Attenuate Obesity and Associated Disorder in Mice: Potential Importance of Cytochrome P450-Derived Omega-3 Fatty Acid Epoxides
by: Yige Wang, et al.
Published: (2025-05-01)

Effect of food components on cytochrome P450 expression and activity
by: Ruoyao Sang, et al.
Published: (2025-06-01)

Bacterial Cytochrome P450 Involvement in the Biodegradation of Fluorinated Pyrethroids
by: Mohd Faheem Khan, et al.
Published: (2025-04-01)

CytochromeP450 2D6 and Atomoxetine Metabolism
by: J Gordon Millichap
Published: (2010-10-01)

The role of nicotinamide-β-adenine dinucleotide phosphate-H-cytochrome P450 oxidoreductase in the activation of cytochromes
by: Popova Olga, et al.
Published: (2025-01-01)

In Vitro and In Vivo Effect of Xylopic Acid on Cytochrome P450 Enzymes
by: Mary A. Agbenyeku, et al.
Published: (2022-01-01)

Valence Bond Insights into the H-Abstraction Barrier in Cytochrome P450
by: Enhua Zhang, et al.
Published: (2025-05-01)

Editorial for the Special Issue “Cytochrome P450 (CYP) in Health and Disease”
by: Alevtina Grishanova
Published: (2025-04-01)

Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation
by: Pradeepraj Durairaj, et al.
Published: (2025-03-01)

Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors
by: Zbigniew Dutkiewicz, et al.
Published: (2018-01-01)

Heterotropic Activation of Cytochrome P450 3A4 by Perillyl Alcohol
by: Ji Hyeon Ryu, et al.
Published: (2024-12-01)

Structure and dynamics of the membrane-bound cytochrome P450 2C9.
by: Vlad Cojocaru, et al.
Published: (2011-08-01)

Engineering Electron Transfer Flux between Cytochrome P450 Enzyme and P450 Reductase to Enhance Serotonin Production in Escherichia Coli
by: Wenzhao Xu, et al.
Published: (2025-08-01)

Fatal poisoning case involving drug interaction due to the inhibition of cytochrome P450
by: Kinoshita Hiroshi, et al.
Published: (2021-01-01)

Cytochrome P-450 3A4 system in patients with acute myocardial infarction
by: A. G. Vladimirov, et al.
Published: (2008-08-01)

Cannabinoids and the endocannabinoid system in the regulation of cytochrome P450 metabolic activity-a review
by: Carlos D.F. Fonseca, et al.
Published: (2025-06-01)

Breast Cancer Cytochromes P450: Chemopreventive and/or Therapeutic Targets for Naturally Occurring Phytochemicals
by: Hanna Szaefer, et al.
Published: (2025-07-01)

Isoform CYP1A2, as a part of the cytochrome P450 superfamily
by: Y. G. Novickaya, et al.
Published: (2014-04-01)

Comparative study of cytochrome P450 expression in the kidneys of Lepus yarkandensis and Oryctolagus cuniculus
by: Jianping Zhang, et al.
Published: (2025-02-01)